CCRN — CROSS CTRY HEALTHCARE INC

Ownership history in Aristotle Capital Boston, LLC  ·  45 quarters on record

AI Ownership Summary

Aristotle Capital Boston, LLC reported CROSS CTRY HEALTHCARE INC (CCRN) in 45 quarterly 13F filings from 2023 Q4 through 2025 Q4. Peak portfolio weight reached 0.63% in 2023 Q4. The latest visible filing shows CCRN at 0.28% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this CCRN ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Aristotle Capital Boston, LLC's position in CROSS CTRY HEALTHCARE INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

CCRN was reported at 0.28% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.63% in 2023 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

CCRN stock page Aristotle Capital Boston, LLC fund profile Aristotle Capital Boston, LLC full holdings
How Aristotle Capital Boston, LLC held CCRN — position size vs. price
% of Fund (quarterly)    CCRN price (quarter-end, indexed to 100)
📋 Quarterly Holdings History 9 quarters  ▾
Quarter Action Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 REDUCED 626,107 -62,889 -9.1% 0.28% $5.1M 2026-02-14 (Est.) $8.08
2025 Q3 REDUCED 688,996 -8,106 -1.2% 0.50% $9.8M 2025-11-14 $11.13
2025 Q2 REDUCED 697,102 -38,639 -5.3% 0.46% $9.1M 2025-08-14 $13.01
2025 Q1 REDUCED 735,741 -124,954 -14.5% 0.55% $11.0M 2025-05-15 $13.95
2024 Q4 REDUCED 860,695 -96,730 -10.1% 0.58% $15.6M 2025-02-14 $18.15
2024 Q3 ADDED 957,425 +49,864 +5.5% 0.43% $12.9M 2024-11-14 $10.01
2024 Q2 REDUCED 907,561 -14,202 -1.5% 0.42% $12.6M 2024-08-14 $14.12
2024 Q1 ADDED 921,763 +7,969 +0.9% 0.52% $17.3M 2024-05-15 $14.75
2023 Q4 ADDED 913,794 +23,391 +2.6% 0.63% $20.7M 2024-02-14 $20.32
36 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

🏢 Other funds also holding CCRN

As of 2026 Q1 — sorted by position size

Ares Financial Consulting, LLC 0.0% Versant Capital Management, Inc 3Y 7Y 0.0% True Wealth Design, LLC 3Y 0.0% GAMMA Investing LLC 0.0% Farther Finance Advisors, LLC 0.0% IFP Advisors, Inc 3Y 7Y 0.0% SIGNATUREFD, LLC 3Y 7Y 0.0%

FAQ About Aristotle Capital Boston, LLC and CCRN

These are the practical questions this page is built to answer before you even open the full history table.

How long has Aristotle Capital Boston, LLC reported owning CCRN?

Aristotle Capital Boston, LLC reported CCRN across 9 quarterly 13F filings, from 2023 Q4 through 2025 Q4.

What was the largest reported CCRN position in Aristotle Capital Boston, LLC's portfolio?

The largest reported portfolio weight for CCRN was 0.63% in 2023 Q4.

What is the latest reported CCRN position on this page?

The most recent filing on this page is 2025 Q4, when Aristotle Capital Boston, LLC reported 626,107 shares, equal to 0.28% of portfolio, with an estimated market value of $5.1M.

What does the chart on this CCRN ownership page compare?

The chart compares Aristotle Capital Boston, LLC's quarterly CCRN portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to Aristotle Capital Boston, LLC Holdings